About FNDR
FNDR is a Healthcare company based in Bengaluru (India) founded in 2013 by R K Shandil. Therapeutics and diagnostics for neglected infectious diseases are developed. The company has 29 employees. Its Indian entity Foundation For Neglected Disease Research reported revenue of ₹13.31 Cr. FNDR offers products and services including Drug Discovery Pipeline, Contract Preclinical Studies, and Diagnostics and Devices Program. Its focus areas include Life Sciences, Infectious Diseases, Drugs and Diversified. Its competitors include Biological E and Serum Institute of India.
Company details
Developer of therapeutics and diagnostics for neglected infectious diseases. This organization conducts research and development in infectious disease drug discovery and development, focusing on therapeutics and diagnostics. It offers preclinical in vitro and animal studies for various pathogens under a fee-for-service model. The company also engages in collaborations with other institutions to advance its research at both preclinical and clinical stages. Funding is primarily through grants and donations. The organization also has a community outreach program focused on disease awareness and skill-building.
- Headquarters Bengaluru, India
- Employees 29
- Founders R K Shandil
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website fndr.in
- Social LinkedIn X
- Legal Name Foundation For Neglected Disease Research
- Date of Incorporation 01 Sep, 2014
- Jurisdiction Bengaluru, Karnataka, India
- Annual Revenue₹13.31 Cr
FY 2024 · +17% YoY
- Net Profit₹2.60 Cr
FY 2024 · 20% margin
- EBITDA₹2.99 Cr
FY 2024 · 22% margin
- Employee Count29
Associated legal entities of FNDR
FNDR operates through Foundation For Neglected Disease Research (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Foundation For Neglected Disease Research CIN U73200KA2014NPL076126 | Active | 01 Sep 2014 | Bengaluru, Karnataka | ₹13.3 Cr | 29 | 5 | View details |
Products & Services of FNDR
FNDR offers a comprehensive portfolio of products and services, including Drug Discovery Pipeline, Contract Preclinical Studies, and Diagnostics and Devices Program.
Develops therapeutics for tuberculosis and malaria diseases
Conducts in vitro and animal tests for pathogens
Focuses on tools for infectious disease detection
Board of directors of Foundation For Neglected Disease Research (FNDR)
Foundation For Neglected Disease Research is the primary company behind FNDR. The board of Foundation For Neglected Disease Research currently have 4 directors; the longest-serving is Radha Krishan Shandil, appointed in 2014. 8 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Radha Krishan Shandil DIN 06927253 | Whole-time director | 05 Sep 2014 | 12 yrs 2 mo | Foundation For Neglected Disease Research |
| Shridhar Narayanan DIN 06534130 | CEO | 10 Jun 2017 | 9 yrs 5 mo | Foundation For Neglected Disease Research |
| Suri Venkatachalam DIN 01095804 | Director | 10 Jun 2017 | 9 yrs 5 mo | Foundation For Neglected Disease Research |
| Hemalatha Krishnamurthy DIN 02000309 | Director | 09 Jul 2020 | 6 yrs 4 mo | Foundation For Neglected Disease Research |
People of FNDR
1 people are tracked at FNDR (1 in leadership); the tracked headcount is 29.
| Name | Role | Group |
|---|---|---|
R K Shandil | Founder | Leadership |
Complete people profiles for FNDR
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of FNDR
Figures of Foundation For Neglected Disease Research, the primary company behind FNDR, for FY 2024. Revenue was ₹13.31 Cr (+17% year on year). Net profit was ₹2.60 Cr (20% margin). EBITDA was ₹2.99 Cr (22% margin). Revenue has grown at a compounded annual rate of +31% over three years and +19% over five years.
- ₹13.31 CrRevenue · FY 2024 · +17% YoY
- ₹2.60 CrNet profit · 20% margin
- ₹2.99 CrEBITDA · 22% margin
- ₹1 LakhPaid-up capital
- 29Employees (provident fund records)
- +31%Revenue CAGR, 3 years
- +19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Foundation For Neglected Disease Research are on its company page.
Detailed financial statements for FNDR
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of FNDR
FNDR has 2 listed competitors in our database. They include Biological E and Serum Institute of India.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biologicale.com | 1953 | Hyderabad, India | 6,099 | Vaccines and therapeutics for multiple diseases are developed and marketed. | ||
| seruminstitute.com | 1966 | Pune, India | 6,617 | Vaccines and immuno-biological drugs for infectious diseases are manufactured. |
Detailed competitors of FNDR
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of FNDR
The website of FNDR (fndr.in) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 9.1% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Fndr
Complete news archive for FNDR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about FNDR
FNDR was founded in 2013.
FNDR is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
FNDR has 29 employees.
The primary company behind FNDR, Foundation For Neglected Disease Research, reported revenue of ₹13.31 Cr for FY 2024, up 17% year on year.
Developer of therapeutics and diagnostics for neglected infectious diseases. This organization conducts research and development in infectious disease drug discovery and development, focusing on therapeutics and diagnostics. It offers preclinical in vitro and animal studies for various pathogens under a fee-for-service model. The company also engages in collaborations with other institutions to advance its research at both preclinical and clinical stages. Funding is primarily through grants and donations. The organization also has a community outreach program focused on disease awareness and skill-building.
FNDR's top competitors include Serum Institute of India and Biological E.
FNDR offers Drug Discovery Pipeline, Contract Preclinical Studies, and Diagnostics and Devices Program.
FNDR operates through Foundation For Neglected Disease Research.
The legal entities of FNDR currently have 4 directors, including Shridhar Narayanan, Suri Venkatachalam, Radha Krishan Shandil and others.